- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01802983
The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction Syndrome
March 1, 2013 updated by: Kun Xiao, Chinese PLA General Hospital
Key Technology Research of the Comprehensive Treatment of Multiple Organ Dysfunction Syndrome
The multiple organ dysfunction syndrome (MODS) has remained the major factor contributing to prolongation of intensive and mortality.
It is reported that the mortality rates have varied between 20% and 100%, depending on number, severity, duration, type and combination, and definition of dysfunction.
In our study, the investigators explore some comprehensive treatment technology to improved outcomes of MODS patients.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100853
- Recruiting
- Chinese PLA General Hospital
-
Contact:
- Xie Lixin, doctor
- Phone Number: +86 010 55499130
- Email: xielx@263.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All subjects were selected from among inpatients who were hospitalized between Jan 2009 and May 2013 in the Respiratory Intensive Care Unit(RICU),Surgical Intensive Care Unit(SICU) and Emergency Intensive Care Unit(EICU).
Description
Inclusion Criteria:
- age > 60 years old;
- presence of altered organ function in an acutely ill patient such that homeostasis cannot be maintained without intervention;
- have trachea intubation after admitting to intensive care unit within 24 hours.
Exclusion Criteria:
- end stage multiple organ failure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the prognostic assessment of aged patients with MODS
Time Frame: 28 days
|
According to the outcomes of 28-day,all the enrolled patients were divided into survival group and death group, clinical datum of which were collected and analysed.
And then these prognosis were evaluated with the current scoring systems [(Acute Physiology and Chronic Health EvaluationⅡ(APACHEⅡ, APACHE Ⅲ), Sample Acute Physiological score(SAPSⅡ), Multiple Organ Dysfunction score(MODS)], the predictive power of which were compared by receiver operating characteristic(ROC) curve.
Finally, a binary logistic regression analysis was performed to evaluate the concerning prognostic factors of MODSE.
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (ANTICIPATED)
December 1, 2013
Study Completion (ANTICIPATED)
December 1, 2013
Study Registration Dates
First Submitted
February 27, 2013
First Submitted That Met QC Criteria
March 1, 2013
First Posted (ESTIMATE)
March 4, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 4, 2013
Last Update Submitted That Met QC Criteria
March 1, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013670808
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Organ Dysfunction Syndrome
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPediatric Sepsis-induced Multiple Organ Dysfunction SyndromeUnited States
-
Assiut UniversityNot yet recruitingPediatric Sepsis-induced Multiple Organ Dysfunction SyndromeEgypt
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingPediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)United States
-
Hospital Universitario Principe de AsturiasPfizerUnknownMultiple Organ Dysfunction SyndromeSpain
-
Advanced Perfusion DiagnosticsCEISOCompletedMultiple Organ Dysfunction SyndromeFrance
-
Hospices Civils de LyonCompletedMultiple Organ Dysfunction SyndromeFrance
-
Martin-Luther-Universität Halle-WittenbergServier; KKS NetzwerkUnknownMultiple Organ Dysfunction SyndromeGermany
-
AM-PharmaCompletedSepsis | Multiple Organ Dysfunction SyndromeNetherlands, Belgium
-
Chang Gung Memorial HospitalUnknownSepsis | Multiple Organ Dysfunction SyndromeTaiwan
-
Efferon JSCRecruitingCardiac Disease | Multiple Organ Dysfunction SyndromeRussia